Roivant Sciences (ROIV)
NASDAQ:ROIV
Holding ROIV?
Track your performance easily

Roivant Sciences (ROIV) Financial Statements

530 Followers

Roivant Sciences Financial Overview

Roivant Sciences's market cap is currently ―. The company's EPS TTM is $5.573; its P/E ratio is 2.16; Roivant Sciences is scheduled to report earnings on November 11, 2024, and the estimated EPS forecast is $-0.23. See an overview of income statement, balance sheet, and cash flow financials.
Jun 24Mar 24Dec 23Sep 23Jun 23
Income Statement-
Total Revenue$ 55.13M$ 28.93M$ 37.14M$ 37.10M$ 16.66M
Gross Profit$ 55.13M$ 24.52M$ 33.47M$ 37.10M$ 21.62M
EBIT$ -213.19M$ -184.28M$ 5.11B$ -318.11M$ -317.18M
EBITDA$ -206.73M$ -179.05M$ 5.11B$ -310.83M$ -309.72M
Net Income Common Stockholders$ 95.30M$ -151.12M$ 5.10B$ -262.66M$ -291.82M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 5.68B$ 6.54B$ 6.67B$ 1.41B$ 1.43B
Total Assets$ 6.50B$ 7.22B$ 7.31B$ 2.07B$ 2.14B
Total Debt$ 379.06M$ 499.75M$ 506.58M$ 497.98M$ 492.63M
Net Debt$ -5.30B$ -6.04B$ -6.16B$ -910.25M$ -941.46M
Total Liabilities$ 601.16M$ 773.95M$ 728.10M$ 739.91M$ 802.51M
Stockholders Equity$ 5.44B$ 5.97B$ 6.09B$ 948.53M$ 910.73M
Cash Flow-
Free Cash Flow$ -193.79M$ -108.81M$ -210.81M$ -196.75M$ -250.29M
Operating Cash Flow$ -192.83M$ -108.46M$ -210.45M$ -196.47M$ -249.89M
Investing Cash Flow$ -965.00K$ 6.93M$ 5.23B$ -36.45M$ 105.00K
Financing Cash Flow$ -660.62M$ -32.62M$ 236.64M$ 207.87M$ 7.48M
Currency in USD

Roivant Sciences Earnings and Revenue History

Roivant Sciences Debt to Assets

Roivant Sciences Cash Flow

Roivant Sciences Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis